Revolutionize
Pharmaceutical
Commercialization
Revolutionize
Pharmaceutical
Patient Services
We Leverage the Power of Agentic Solutions to Reshape the Commercialization of Pharmaceutical Products.
Better For Patients
Better For Providers
Better For Manufacturers
The Company We Keep
Simplify Patient Engagement with Agentic Solutions.
After receiving a prescription, a patient enters a complex journey navigating benefits investigation, securing prior authorization approvals, and coordinating pharmacy fulfillment. Each step presents administrative hurdles, delays, and cost uncertainties that must be resolved before they can access affordable medication. Phluence simplifies how patients gain support from manufacturers with:
- Proactive Engagement: Go upstream with in-EHR and Digital Ad pipeline to capture consented patients and drive volume to your programs through Conversational and Voice Assistance.
- Dynamic Personalization: Deploy hyper-personalized interactions based on individual patient healthcare dynamics to deliver support that matches the needs and evolves over time.
- First Party Data Generation: Agentic patient engagement collects valuable data during every interaction, enabling Brands to identify trends and intervene earlier in cases of benefit management, non-adherence, or therapy dropout.
Deploy Intelligent Workflow Solutions for Field Teams, HCPs and Patient Support Teams.
Legacy patient services models, which incorporate FTE-based call centers, emails, and numerous physician apps and portals, are complicated and costly. As this administrative burden escalates the cost of U.S. healthcare, the need for agile and cost-effective patient engagement models continues to grow. Phluence delivers the right technology tools to patient services teams:
- FRM Solutions: Enable prescriptive command of field access execution at scale by transferring administrative, analytical, and data-entry tasks from the FRM to autonomous software agents. Reduce the burden and reliance on downstream support teams and solve problems onsite.
- HCP Solutions: Deploy the next generation of solutions for engaging HCPs and office staff by migrating them from legacy HCP and Patient Portals to virtual in-office agentic support that drives case submission quality and simplifies patient’s access to Brand programs.
- Market Access Insight Solutions: Empower management and operations teams with the deep problem-solving capability of the Phluence agentic assistants trained on the complex channel, market access, and competitive dynamics for your Brand. Reduce the time to insight, time to action, and case-specific firefighting.
Prevent Revenue Leakage and Recapture Lost Revenue.
The complexities of pharmaceutical commercialization make it challenging to maximize
revenue. Manufacturers must do more than increase sales — they must implement a robust
revenue optimization strategy and leverage sophisticated technology. The Phluence Platform
includes synchronized tools and workflows to prevent revenue leakage and capitalize on
growth opportunities in both private and public channels.
- Benefit Sentinel Solution: Proactively monitor patient benefit carve-outs to address the Accumulator and Maximizer impact, claw back duplicative 340b rebates, and deploy safeguards against patient loss to Alternate Funding Program mechanisms to protect your Brand’s gross-to-net.
- Annual Reverification and Reenrollment: Significantly reduce the spend on reverification and reenrollment for patients into programs by deploying market-proven agentic outreach and workflow solutions.
- Bridge Conversion Solutions: Successfully transition a patient from a temporary manufacturer-sponsored bridge program to permanent coverage through an intentional, structured process of navigating the insurance, authorization, and financial aid systems to get the patient on a covered prescription status.
How can Phluence™
help you?
We’re reshaping the commercialization of pharmaceutical products with advanced technologies — and advanced thinking.
*Required fields
Please read our Privacy Policy to see how we use your personal information.
The Phluence™ Platform Brings Together Powerful Technology Plus Trusted Industry Insights For World-Class Pharmaceutical Commercialization.
Phluence works at the intersection of Patient Support and AI. Our pharmaceutical commercialization solutions are built using a deep understanding of market access and reimbursement policies combined with advanced AI technologies, next-generation analytics capabilities, and automation.
News & Insights
Part 1 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue & Patient Care Alternate Funding Programs have evolved into a powerful but largely invisible force in specialty pharma—reshaping patient access, distorting brand
Recent Articles
Part 4 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...
April 21, 2026
Part 1 of Our Series: Reimagining Patient Services with Conversational AI Conversational AI enables pharmaceutical...
April 21, 2026
Part 2 of Our Series: Reimagining Patient Services with Conversational AI What does “infinite engagement”...
April 21, 2026
The Emerging Prerequisite to Drug Affordability: Digital Patient Engagement Drug affordability is one of the...
April 21, 2026
Part 2 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...
April 23, 2026
Part 3 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...
April 23, 2026
The Emerging Prerequisite to Drug Affordability: Digital Patient Engagement Drug affordability is one of the...
April 21, 2026
Part 2 of Our Series: Reimagining Patient Services with Conversational AI What does “infinite engagement”...
April 21, 2026
- All
- Affordability
- AFPs
- Blog
- Conversational AI
- Patient Engagement
- Specialty Medicines
Part 1 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...
April 23, 2026
Part 2 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...
April 23, 2026
Part 3 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...
April 23, 2026
The Emerging Prerequisite to Drug Affordability: Digital Patient Engagement Drug affordability is one of the...
April 21, 2026
Part 2 of Our Series: Reimagining Patient Services with Conversational AI What does “infinite engagement”...
April 21, 2026
Part 1 of Our Series: Reimagining Patient Services with Conversational AI Conversational AI enables pharmaceutical...
April 21, 2026